Healthcare Investment Banking

Amidst rapidly changing technologies and groundbreaking scientific discoveries, the healthcare industry is constantly evolving. Keeping the pace is the Healthcare Investment Banking group of Raymond James, one of the oldest, largest and most successful healthcare-focused advisory services practices in the U.S. in terms of domain expertise, dedicated resources and track record. Our well-recognized investment banking practice has more than 80 professionals focused exclusively on advising middle-market companies across the healthcare services, pharmaceuticals & pharmaceuticals services, medical technology & diagnostics, biotechnology and healthcare technology sectors. We have completed more than 250 M&A transactions and have longstanding relationships with an expansive network of healthcare-focused equity sponsors.

Healthcare Sector Expertise

 

  • Healthcare Services
  • Healthcare Technology
  • Life Sciences
  • Medical Technology & Diagnostics
June 2025 embold health portfolio company of echo morgan health has agreed to be acquired by quantum health portfolio company of great hill partners warburg pincus

June 2025

About Embold Health

Embold Health, a healthcare technology company, helps employers and health plans improve outcomes and lower costs by empowering members to make informed healthcare decisions. 
May 2025 Guardian Pharmacy Services Follow-On Offering Left Bookrunning Manager $181,125,000

May 2025

About Guardian Pharmacy

Guardian Pharmacy Services provides a suite of technology-enabled services tailored to serve the needs of residents of long-term health care facilities, primarily in its target markets of assisted living facilities, behavioral health facilities, and group homes. 
May 2025 Hinge Health Initial Public Offering Passive Bookrunning Manager $502,905,600

May 2025

About Hinge Health

Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. 
May 2025 Waystar Follow-On Offering Co-Manager $557,031,250

May 2025

About Waystar

Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance.
May 2025 i3 Verticals Healthcare RCM Business acquired by Infinx a portfolio company of KKR Norwest

May 2025

About i3 Verticals

i3 Verticals Healthcare RCM business provides a practice optimization platform offering technology-enabled RCM, practice management, patient engagement and EHR solutions.
April 2025 Liminatus Pharma has merged with IRIS acquisition corp. Arrow Capital Sellside Advisor

April 2025

About Liminatus Pharma

Liminatus Pharma, LLC (“Company” or “Liminatus”) is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies. 
April 2025 Pelthos Therapeutics subsidiary of Ligand has agreed to merge with Channel Therapeutics

April 2025

About Pelthos

Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens.
April 2025 Gritstone Bio acquired by Seattle Project Corp, Hercules Capital, Future Solutions supported by DIP Financing from Future Solutions and confirmed its Plan of Reorganization Financial Advisor to the Company

April 2025

About Gritstone

Gritstone bio, Inc. was a clinical-stage biotechnology company that aimed to develop the world’s most cutting-edge vaccines.
March 2025 Nova Medical Centers acquired by Concentra Financial Advisor

March 2025

About Nova Medical Centers

Nova Medical Centers (“Nova” ) is a leading provider of occupational health services in the United States. Nova’s services focus on providing employers with pre-employment health screenings and treatment for work-related injuries.
February 2025 Waystar Follow-On Offering Co-Manager $800,000,000

February 2025

About Waystar

Waystar's software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance.
January 2025 Horizon Infusions portfolio company of BroadOak Capital Partners has been recapitalized by Rubicon Founders Financial Advisor

January 2025

About Horizon Infusions

Horizon Infusions is Ohio’s leading network of infusion centers, committed to delivering expert care in a low-cost, patient-focused environment. 
January 2025 Stragen Services portfolio company of Archimed acquired by PLG

January 2025

About Stragen Services

Stragen Services is a lyon-based pharmacovigilance and clinical safety services provider and has established itself as a reliable partner for the European Pharma, Biotech, and Medtech community.
January 2025 Aptyx a portfolio company of Truarc Partners has acquired Medical Murray Charlotte, NC Facility Financial Advisor

January 2025

About Aptyx

Aptyx is a global manufacturing partner that engineers smart solutions to help customers solve tough challenges with confidence.
December 2024 FC2 Female Condom business of Veru acquired by Riva Ridge Capital Management

December 2024

About Veru Inc.

Veru is a late clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases and oncology. 
December 2024 HUB Organoids acquired by Merck Sellside Advisor

December 2024

About HUB Organoids

HUB Organoids is a global leader in the field of adult stem cell-derived organoids. HUB Organoid Technology represents a paradigm shift for drug discovery and development, preclinical patient stratification, predictive diagnostics, etc.
December 2024 Lomond Therapeutics Alternative Public Offering Lead Placement Agent $54,000,000

December 2024

About Lomond Therapeutics

Lomond Therapeutics is a biopharmaceutical company, focused on the development of best-in-class and first-in-class small molecule inhibitors that target escape mutations in hematologic and solid cancers.
December 2024 Nationwide Medical acquired by Heritage Group supported by acquisition financing arranged by Raymond James

December 2024

About HeritageGroup

Heritage Group is a Nashville‐based, healthcare‐focused investment firm with more than 35 years of experience financing and operating healthcare companies at all stages. 
November 2024 Center for Social Dynamics portfolio company of NMS Capital has been recapitalized by Goldman Sachs Alternatives Financial Advisor

November 2024

About Center for Social Dynamics

The Center for Social Dynamics is a premier provider of Applied Behavior Analysis (ABA) services, specializing in personalized, evidence-based treatment for Autism Spectrum Disorder (ASD) delivered in home-based settings.
September 2024 SkinCure Oncology A portfolio company of Seacoast Capital Has been recapitalized by H.I.G. Capital

September 2024

About SkinCure Oncology

Founded in 2016, SkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer.
September 2024 Guardian Pharmacy Services $128,800,000 Initial Public Offering Left Bookrunning Manager

September 2024

About Guardian Pharmacy Services

Guardian Pharmacy Services provides a suite of technology-enabled services tailored to serve the needs of residents of long-term health care facilities (LTCFs), primarily in its target markets of assisted living facilities and behavioral health facilities and group homes. 
November 2024 Evive portfolio company of Susquehanna Growth Equity acquired bswift portfolio company of Francisco Partners

September 2024

About Evive Health

Evive is a digital communications and engagement platform that helps health plans and employers optimize the benefits, resources and programs they offer their employees. 
September 2024 ANI Pharmaceuticals Has acquired Alimera

September 2024

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need.
September 2024 Relay Therapeutics Follow-On Offering Co-Manager $230,000,000

September 2024

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients.
September 2024 Xencor $201,250,000 Follow-On Offering Bookrunning Manager

September 2024

About Xencor

Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases.
August 2024 Avidity Biosciences Follow-On Offering Co-Manager $345,100,000

August 2024

About Avidity Biosciences

Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates (AOCs™).
July 2024 Valenz portfolio company of Kelso Private Equity acquired by Healthcare Bluebook portfolio company of Primus

July 2024

About Valenz

Vālenz Health is the platform to simplify healthcare – the destination for employers, payers, providers and members to reduce costs, improve quality, and elevate the healthcare experience.
July 2024 Montagu Has acquired the Medical Device Components Business of Johnson Matthey

July 2024

About Johnson Matthey

Johnson Matthey is a global leader in sustainable technologies. For over 200 years the Company has used advanced metals chemistry to tackle the world's biggest challenges. 
June 2024 Addus HomeCare $162m Follow-On Offering Co-Manager

June 2024

About Addus HomeCare

Addus is a provider of comprehensive home care services that include, primarily, personal care services that assist with activities of daily living, as well as hospice and home health services. 
June 2024 Health-E Commerce A portfolio company of BPOC Has been acquired by HIG Capital

June 2024

About Health-E Commerce

Health-E Commerce is the parent brand to FSA Store and HSA Store, online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts.
June 2024 Waystar $967.5m Initial Public Offering Co-Manager

June 2024

About Waystar

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments.
June 2024 HIG Growth Partners Has acquired Mobile Health

June 2024

About HIG Growth

H.I.G. Growth Partners is the dedicated growth capital investment affiliate of H.I.G. Capital, a leading global alternative investment firm with $64 billion of capital under management based on total capital raised by H.I.G. Capital and its affiliates.
June 2024 Ceapro Has merged with Aeterna Zentaris

June 2024

About Aeterna Zentaris

Aeterna is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of significant unmet medical need. 
May 2024 Dyne Therapeutics Follow-On Offering Co-Manager $374,300,000

May 2024

About Dyne Therapeutics

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.
May 2024 Gen4 A portfolio company of Thurston Group $315m Senior Debt Financing Placement Agent

May 2024

About Gen4 Dental Partners

Gen4 Dental Partners is a leading dental service organization committed to providing comprehensive practice support services to dental practices across the United States. 
May 2024 Pacira BioSciences $287.5m Convertible Debt Offering Co-Manager

May 2024

About Pacira BioSciences

Pacira is a commercial biopharmaceutical company focused on developing, manufacturing and marketing non-opioid pain management solutions. 
May 2024 US Foot & Ankle Specialists A portfolio company of NMS Capital Debt financing provided by TPG Audax Private Debt Financial Advisor

May 2024

About US Foot and Ankle Specialists

US Foot & Ankle Specialists, LLC is a leading provider of podiatric services in the Mid-Atlantic. USFAS provides a comprehensive suite of podiatric services, offering general podiatry, advanced treatment options for diabetic conditions, and arthroscopic and foot surgery.
April 2024 Completed a credit advisory engagement for AAPC Special Committee of the Board A portfolio company of Global Growth

April 2024

About AAPC

AAPC is the nation's largest education and credentialing organization for medical coders, billers, auditors, practice managers, documentation specialists, compliance officers, and revenue cycle managers. 
April 2024 Societal CDMO Has been acquired by CoreRx A portfolio company of QHP Capital

April 2024

About Societal CDMO

Societal CDMO is a contract development and manufacturing organization with capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. 
March 2024 Eupraxia C$33,868,000 Follow-On Offering Bookrunning Manager

March 2024

About Eupraxia

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. 
March 2024 RadNet $230,230,000 Follow-On Offering Bookrunning Manager

March 2024

About RadNet

RadNet, Inc., is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue.
March 2024 BridgeBio $287.5m Follow-On Offering Lead Manager

March 2024

About BridgeBio

BridgeBio is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers.
March 2024 Viking Therapeutics $632,540,000 Follow-On Offering Bookrunning Manager

March 2024

About Viking Therapeutics

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials. 
January 2024 Lipocine Has entered into an exclusive licensing agreement with Verity Up to $270m

January 2024

About Lipocine

Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for CNS disorders. 
January 2024 Dianthus Therapeutics $230m PIPE Placement Agent

January 2024

About Dianthus Therapeutics

Dianthus Therapeutics is a biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies.
January 2024 Dyne Therapeutics $345,100,000 Follow-On Offering Co-Manager

January 2024

About Dyne Therapeutics

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. 
December 2023 Ocular Therapeutics  $115,115,000 Follow-On Offering Co-Manager

December 2023

About Ocular Therapeutics

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology ELUTYX™. 
December 2023 Heart + Paw A portfolio company of Waud Capital Has received an investment from Whistler Capital Partners

December 2023

About Heart Paw

Founded in 2018, Heart + Paw is a differentiated, rapidly growing pet care services platform offering veterinary care, grooming, day care and boarding. 
December 2023 Bluebird $125m Follow-On Offering Co-Manager

December 2023

About Bluebird

Bluebird bio is a biotechnology company committed to researching, developing, and commercializing potentially curative transformative gene therapies for severe genetic diseases based on their lentiviral vector (LVV) gene addition platform.
December 2023 Visant Medical Has been acquired by Amring Pharmaceuticals A subsidiary of Nordic Pharma

December 2023

About Visant Medical

Visant Medical focuses on the treatment of dry eye disease. The Company's FDA cleared medical device, LACRIFILL®, is indicated to help patients experiencing dry eye symptoms by blocking tear drainage through occlusion of the canalicular system.
December 2023 Veru $37,950,000 Follow-On Offering Bookrunning Manager

December 2023

About Veru

Veru Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology and viral-induced acute respiratory distress syndrome.
December 2023 89bio $172.5m Follow-On Offering Bookrunning Manager

December 2023

About 89bio

89bio is a clinical-stage biopharmaceutical company dedicated to the development of therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options.
December 2023 Wave Life Sciences $100m Follow-On Offering Co-Manager

December 2023

About Wave Life Sciences

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases.
September 2023 Novan Has been acquired by Ligand Mayne Pharma

September 2023

About Novan Inc

Novan, Inc. is a commercial stage specialty dermatology company based in Durham, NC. The Company utilizes its proprietary Nitricil platform, which facilitates the stabilization and delivery of nitric oxide (NO), to research and develop novel therapeutics for the treatment of skin diseases. 
September 2023 Slayback Pharma A portfolio company of KKR Everstone Capital Has been acquired by Azurity Pharmaceuticals

September 2023

About Slayback

Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and Europe.
September 2023 2309_CymaBay $258,750,000 Follow-On Offering Bookrunning Manager

September 2023

About CymaBay Therapeutics

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies.
 
September 2023 Dianthus Therapeutics $70m PIPE Placement Agent

September 2023

About Dianthus Therapeutics

Dianthus Therapeutics is a biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies. 
August 2023 Nextech A portfolio company of THL Has been acquired by TPG $1.4 Billion

August 2023

About Nextech Systems

Nextech is the complete healthcare technology solution for specialty providers including Dermatology, Ophthalmology, Orthopedics, Plastic Surgery, and Med Spa.
August 2023 MedTech Acquisition Corporation Has closed a business combination with TriSalus

August 2023

About MedTech Acquisition

MedTech Acquisition Corporation is a special purpose acquisition company with a focus on the medical technology industry in the United States and other developed countries.
August 2023 Limeade Has been acquired by WebMD health services A portfolio company of Internet Brands

August 2023

About Limeade

Limeade is an immersive employee well-being company that creates healthy employee experiences. Limeade reduces burnout and turnover while increasing well-being and engagement – ultimately elevating business performance.
 
August 2023 HealthPay24 A subsidiary of EngageSmart Has been acquired by Waystar

August 2023

About EngageSmart

EngageSmart is a provider of vertically tailored customer engagement software and integrated payments solutions. 
August 2023 Oncap Has invested into Biomerics And merger with Precision Concepts Medical Portfolio companies of Oncap

August 2023

About Biomerics

Founded in 1994, Biomerics is a leading medical device contract manufacturer serving the interventional device market. 
July 2023 BRi A portfolio company of CIP Capital Has been acquired by Millennium Trust Company A portfolio company of Abry Partners Parthenon Capital Partners

July 2023

About Benefit Resource LLC

BRI, founded in Rochester, New York in 1993, is a leader in technology enabled solutions for tax-free employee benefit plans that streamline plan administration, reduce overhead costs for employers and improve convenience and security for employees.
July 2023 VBI Vaccines Follow-On Offering Sole Bookrunning Manager

July 2023

About VBI Vaccines

VBI Vaccines Inc. is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. 
July 2023 PaceMate A portfolio company of Ballast Point Ventures Has been recapitalized by Lead Edge Capital

July 2023

About PaceMate

PaceMate offers the most comprehensive remote cardiac monitoring solution in the industry. 
June 2023 Comvest Partners Has acquired Your Behavioral Health

June 2023

About Your Behavioral Health

Your Behavioral Health is a leading regional behavioral health services platform that provides comprehensive best-in-class services for adults and teens across the continuums of mental health and addiction treatment.
June 2023 RadNet $259,160,000 Follow-On Offering Bookrunning Manager

June 2023

About RadNet

RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. 
May 2023 PLx Pharma Has been acquired by MPG

May 2023

About PLx Pharma

PLx Pharma Inc. is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses.
May 2023 Adamis Has merged with DMK Pharmaceuticals

May 2023

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation was a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose and allergy. 
April 2023 Nielsen BioSciences Has entered into an exclusive licensing agreement with Maruho $100m

April 2023

About Nielsen BioSciences

Nielsen BioSciences is a privately held biotechnology company based in San Diego and founded in 2013. 
April 2023 InflaRx $46m Follow-On Offering Sole Bookrunning Manager

April 2023

About InflaRx

InflaRx is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. 
April 2023 Viking Therapeutics $287.5m Follow-On Offering Bookrunning Manager

April 2023

About Viking Therapeutics

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials. 
March 2023 89bio $316,250,000 Follow-On Offering Bookrunning Manager

March 2023

About 89bio

89bio is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases. 
March 2023 JATT acquisition corp Has acquired zurabio

March 2023

About Zura Bio

Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.
February 2023 Apellis Pharmaceuticals Inc $402.5m Follow-On Offering Co-Manager

February 2023

About Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
January 2023 Sol-Gel Technologies Ltd $22.8m Registered Direct Offering & PIPE Sole Placement Agent

January 2023

About Sol-Gel Technologies Ltd

Sol-Gel is a dermatology company focused on identifying, developing and commercializing or partnering topical drug products for the treatment of skin diseases.
January 2023 CymaBay Therapeutics Inc $97,750,000 Follow-On Offering Bookrunning Manager

January 2023

About CymaBay Therapeutics Inc

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies.
 
January 2023 Chiesi Has acquired PhaseBio

January 2023

About Chiesi

Based in Parma, Italy, Chiesi is an international research-focused pharmaceuticals and healthcare group with over 85 years' experience, operating in 30 countries with more than 6,000 employees. 
January 2023 Highland Park Animal Hospital Has been acquired by innovetive A portfolio company of Metalmark Capital

January 2023

About Highland Park Animal Hospital

The Highland Park Family of Practices is a network of animal hospitals and a luxury boarding facility in Dallas County. 
December 2022 Avidity Biosciences $238m Follow-On Offering Lead Manager

December 2022

About Avidity Biosciences

Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates. 
December 2022 Myrtelle $24m Private Placement Exclusive Advisor

December 2022

About Myrtelle

Myrtelle Inc. is a gene therapy company focused on developing transformative treatments for neurodegenerative diseases. 
December 2022 ADMA Biologics $69m Follow-On Offering Bookrunning Manager

December 2022

About ADMA Biologics

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
November 2022 G1 Therapeutics $50m Follow-On Offering Lead Bookrunning Manager

November 2022

About G1 Therapeutics

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the company’s first commercial product, COSELA®. 
November 2022 Gateway Genomics Has been acquired by Myriad genetics

November 2022

About Gateway Genomics

Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children.
October 2022 Clarus Therapeutics Holdings Has been acquired by tolmar

October 2022

About Clarus Therapeutics Holdings

Clarus Therapeutics was a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women.
August 2022 Medidee acquired by Veranex portfolio company of Summit Partners

August 2022

About Medidee

Medidee Services is a leading pan-European MedTech consulting boutique offering cutting edge consulting and clinical services in the most sought-after areas including IVD, digital health, cybersecurity, and machine learning.
July 2022 LumiraDx Follow-On Offering Bookrunning Manager $75,250,000

July 2022

About LumiraDx

LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, LumiraDx manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. 
July 2022 LumiraDx Private Placement Capital Markets Advisor $25,000,000

July 2022

About LumiraDx2

LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, LumiraDx manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care.
July 2024 Montagu Has acquired the Medical Device Components Business of Johnson Matthey

July 2022

About Montagu Private Equity LLP

Medical Device Components (MDC) develops and manufactures complex and high-precision miniature components for minimally invasive medical devices used in high-growth clinical specialties.
June 2022 89bio Follow-On Offering Bookrunning Manager $94,500,000

June 2022

About 89bio

89bio is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases. 
June 2022 Sandstone Care has been recapitalized by Vistria

June 2022

About Sandstone Care

Sandstone Care is a leading provider of high-quality care for young people with behavioral and mental health conditions.
May 2022 Tarsus $75.6M Follow-On offering  Bookrunning Manager

May 2022

About Tarsus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention.
May 2022 ALung has been acquired by LivaNova

May 2022

About Alung Technologies

ALung Technologies, Inc. is a privately held Pittsburgh-based developer and manufacturer of innovative lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung, an FDA-cleared dialysis-like alternative or supplement to mechanical ventilation.
April 2022 Aurion  Biotech $120M Private placement Exclusive Financial Advisor

April 2022

About Aurion Biotech

Aurion Biotech is a clinical-stage biotech company. Aurion's mission is to restore vision to millions of patients with its life-changing regenerative therapies.
March 2022 Apellis $402.5M Follow-On Offering Lead Manager

March 2022

About Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
March 2022 Argenix $805M Follow-On Offering Co-Manager

March 2022

About Argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program, argenx aims to translate immunology breakthroughs into a portfolio of novel antibody-based medicines.
March 2022 Urgent Care Group has been acquired by Total Access Urgent Care a portfolio company of ICV

March 2022

About Urgent Care Group

Based in Nashville, TN, Urgent Care Group is creating the leading urgent care company by combining and developing the best urgent care centers in partnership with leading urgent care providers and health systems.
March 2022 HealthSavings a portfolio company of Bluffpoint Associates has sold its HSA accounts to HealthEquity

March 2022

About HealthSavings

With a 15 –year track record serving the unique needs of growing businesses, HealthSavings offers the services and education needed to implement and scale a successful health savings benefit offering.
February 2022 Teligent has been acquired via 363 sale transaction by multiple companies $87,170,000

February 2022

About Teligent

Teligent was a topical and injectable pharmaceutical company based in Buena, New Jersey with manufacturing and marketing capabilities in the United States and virtual pharmacy operations in Canada.
May 2017 Flexion Therapeutics $201,250,000 convertible notes offering co-manager

January 2022

About 1705_Flexion Therapeutics

Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (“OA”).
January 2022 Viscogliosi Brothers Acquisition Corp $75M Initial Public Offering Sole Bookrunning Manager

January 2022

About Viscogliosi Brothers Acquisition Corp.

Viscogliosi Brothers Acquisition Corp. is a newly organized blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
December 2021 West Hills Animal Hospital Family of Practices has partnered with Innovetive Petcare a portfolio company of Metalmark Capital

December 2021

About West Hills Animal Hospital Family of Practices

Serving Long Island pets for nearly 40 years, the West Hills Animal Hospital Family of Practices is one of Long Island's largest, longest tenured and most respected veterinary practices.
December 2021 Anovo has completed a minority recapitalization with TPG Growth

December 2021

About Anovo

Founded in 2013 by a team of specialty pharmacy industry veterans, Anovo provides a comprehensive end-to-end suite of services to help manufacturers plan for and launch specialty products for patients with rare diseases and often difficult and devastating complex conditions.
November 2021 CymaBay Therapeutics $75M follow-on offering boookrunning manager

November 2021

About CymaBay Therapeutics

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need.
November 2021 Definitive Healthcare $396M follow-on offering  co-manager

November 2021

About Definitive Healthcare

Definitive Healthcare is a leading provider of healthcare commercial intelligence. The Company’s solutions provide accurate and comprehensive information on healthcare providers and their activities to help its customers optimize everything.
November 2021 Apellis Pharmaceuticals $402,500,000 follow-on offering co-lead manager

November 2021

About Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
November 2021 Alignment Healthcare $168M follow-on offering bookrunning manager

November 2021

About Alignment Healthcare Inc.

Alignment Healthcare is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans.
November 2021 LianBio $325M initial public offering lead manager

November 2021

About LianBio

LianBio is a global, science-driven biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets.
November 2021 ANI Pharmaceuticals, Inc. $75M follow-on offering bookrunning manager

November 2021

About ANI Pharmaceuticals Inc.

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company focused on delivering value to customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.
November 2021 Compass Therapeutics $125M follow-on offering bookrunning manager

November 2021

About Compass Therapeutics

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases.
October 2021 AirSculpt Technologies $77M initial public offering co-manager

October 2021

About AirSculpt Technologies

AirSculpt is an experienced, fast-growing national provider of body contouring procedures delivering a premium consumer experience.
October 2021 ADMA Biologics $57,500,000 follow-on offering bookrunning manager

October 2021

About ADMA Biologics

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients.
October 2021 Xilio Therapeutics $117,600,000 initial public offering lead manager

October 2021

About Xilio Therapeutics

Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
October 2021 HealthEquity $100M senior notes offering co-manager

October 2021

About HealthEquity

HealthEquity administers health savings accounts (HSAs) and other consumer directed benefits for more than 13 million accounts in partnership with employers, benefits advisors and health and retirement plan providers.
September 2021 LumiraDx has merged with CA Healthcare $3,000,000,000

September 2021

About LumiraDx

LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare.
September 2021 Leap Therapeutics $104,000,000 follow-on offering bookrunning manager

September 2021

About Leap Therapeutics

Leap Therapeutics is focused on developing targeted and immuno-oncology therapeutics.
September 2021 Definitive Healthcare $483,000,000 initial public offering  co-manager

September 2021

About Definitive Healthcare

Definitive Healthcare is a leading provider of healthcare commercial intelligence. The Company’s solutions provide accurate and comprehensive information on healthcare providers and their activities to help its customers optimize everything.
September 2021 Lake Eye Associates has been acquired by US Eye a portfolio company of Pamlico

September 2021

About Lake Eye Associates

Lake Eye Associates has dedicated 40 years to delivering a full range of services, from general eye care to ground-breaking cataract surgery and LASIK surgery, and even cosmetic eyelid surgery.
August 2021 Rafael Holdings Inc $104,170,000 PIPE placement agent

August 2021

About Rafael Holdings Inc.

Rafael Holdings is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies - Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
August 2021 Brainstorm Cell Therapeutics $52,201,000 at-the-market offering agent

August 2021

About Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.
August 2021 Strategic advisory for Epigenomics AG including the sale of selected assets to New Horizon Health

August 2021

About Epigenomics AG

Epigenomics AG is a molecular diagnostics company focused on blood testing for the early detection of cancer.
August 2021 Health Catalyst $225,000,000 follow-on offering co-manager

August 2021

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement.
August 2021 Ovia Health has been acquired by Labcorp

August 2021

About Ovia Health

Ovia Health helps employers, health plans, and consultants provide standout benefits to their populations as the only maternal health solution clinically proven to effectively identify and intervene with high-risk conditions.
August 2021 Harmony Biosciences LLC $300,000,000 private debt offering advisor

August 2021

About Harmony Biosciences LLC

Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare neurological diseases who have unmet medical needs.
July 2021 Neurogastrx has entered into a licensing agreement for fexuprazan with Daewoong

July 2021

About Neurogastrx

Neurogastrx, Inc. is a privately held specialty pharmaceutical company developing transformative therapies to advance the treatment of GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden.
July 2021 JATT Acquisition Corp $138,000,000 initial public offering sole bookrunning manager

July 2021

About JATT Acquisition Corp.

JATT Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
June 2021 Progenity $40,000,000 PIPE placement agent

June 2021

About Progenity

Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.
June 2021 Doximity $605,800,000 initial public offering co-manager

June 2021

About Doximity Inc.

Doximity is a digital platform for U.S. medical professionals, with over 1.8 million medical professional members.
June 2021 Leukocare AG has received a growth investment from Petrichor

June 2021

About Leukocare AG

Leukocare AG, located in Martinsried/Munich, Germany and Milford, MA, USA, is a biotechnology company specialized in the field of biopharmaceutical formulation development.
June 2021 ADVANZ PHARMA has been acquired by Nordic Capital $2,115,000,000

June 2021

About ADVANZ PHARMA

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe.
June 2021 PLx Pharma Inc $35,250,000 secondary share sale sole agent

June 2021

About PLx Pharma Inc

PLx Pharma Inc. is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products.
June 2021 Summit Spine and Joint Centers a portfolio company of Fulcrum has been acquired by Msouth Equity Partners

June 2021

About Summit Spine and Joint Centers

Headquartered in Lawrenceville, GA, Summit Spine & Joint Centers (“Summit Spine”) is a leading regional provider of interventional pain management services in 17 locations across the southeastern United States.
May 2021 Veterinary Care Group has been acquired by NVA

May 2021

About Veterinary Care Group

Headquartered in Little Neck, NY, Veterinary Care Group (“VCG”) owns and operates one of New York City’s largest network of veterinary clinics. VCG provides both general practice and pet resort services through its 14 hospital locations throughout Brooklyn and Long Island, New York and Denver, Colorado.
May 2021 Veterans Evaluation Services has been acquired by Maximus $1,400,000,000

May 2021

About Veterans Evaluation Services

VES is the nation’s largest privately-held contractor of outsourced Compensation and Pension Medical Disability Examinations contracting with the U.S. Department of Veterans Affairs.
April 2021 Aveanna Healthcare $458,832,000 initial public offering co-manager

April 2021

About Aveanna Healthcare

Aveanna Healthcare is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna directly address the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.
April 2021 iProcedureshas been acquired by Provation

April 2021

About iProcedures

iProcedures delivers innovative solutions to fill critical gaps in electronic perioperative documentation, which enables users to collect, share and analyze the critical data necessary to improve overall performance.
April 2021 Product Life Group a portfolio company of 21 Invest has acquired DS Inpharmatics

April 2021

About Product Life Group

ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions.
April 2021 Agiliti Inc $368,400,000 initial public offering co-manager

April 2021

About Agiliti Inc.

Agiliti is an essential service provider to the U.S. healthcare industry with solutions that help support a more efficient, safe and sustainable healthcare delivery system. Agiliti serves more than 7,000 national, regional and local acute care and alternate site providers across the U.S.
April 2021 Phreesia $225,000,000 follow-on offering co-manager

April 2021

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. The company’s innovative SaaS platform engages patients in their healthcare and provides a modern, consistent experience.
March 2021 Haemonetics $500,000,000 convertible senior notes co-manager

March 2021

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare.
March 2021 Plx Pharma Inc $71,398,000 follow-on offering bookrunning manager

March 2021

About Plx Pharma Inc.

PLx Pharma is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products.
March 2021 Medical Imaging Associates has been acquired by Radiology Partners a portfolio company of NEA and Starr

March 2021

About Medical Imaging Associates

Medical Imaging Associates (MIA) provides radiology services to approximately 70 healthcare facilities across Idaho, Wyoming and Montana comprising Community Health Systems, hospitals and outpatient imaging locations.
March 2021 InflaRx $75,000,000 follow-on offering bookrunning manager

March 2021

About InflaRx

InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
February 2021 Quantros has been acquired by Healthcare Bluebook

February 2021

About Quantros

Quantros is a leading provider of software and services that advance healthcare performance. Their Software-as-a-Service-based applications help thousands of hospitals and the nation’s leading health systems along with brokers, insurers, TPAs and other key industry players capture actionable intelligence they can use to improve outcomes.
February 2021 Ibere Pharmaceuticals $138,000,000 initial public offering sole bookrunning manager

February 2021

About Ibere Pharmaceuticals

Ibere Pharmaceuticals is a blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which the company refers to throughout the prospectus as its initial business combination.
February 2021 Progenity $25,000,000 PIPE co-placement agent

February 2021

About Progenity

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine.
February 2021 BridgeBio Pharma $215,625,000 secondary share sale co-manager

February 2021

About BridgeBio Pharma

BridgeBio Pharma is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source.
February 2021 NexImmune $126,508,000 initial public offering bookrunning manager

February 2021

About NexImmune

NexImmune is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response that mimics natural biology.
February 2021 BioTelemetry Inc has been acquired by Philips $2,800,000,000

February 2021

About BioTelemetry Inc

BioTelemetry, Inc. is the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.
February 2021 Landos Biopharma $100,000,000 initial public offering lead manager

February 2021

About Landos Biopharma

Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways.
February 2021 Adamis Pharmaceuticals $51,750,000 follow-on offering sole bookrunning manager

February 2021

About Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease.
January 2021 Lipocine $28,750,000 follow-on offering sole bookrunning manager

January 2021

About Lipocine

Lipocine Inc. is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery technologies.
January 2021 CareDx Inc $175,000,000 follow-on offering co-manager

January 2021

About CareDx Inc

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
January 2021 Catalyst Biosciences $50,025,000 follow-on offering bookrunning manager

January 2021

About Catalyst Biosciences

Catalyst Biosciences is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems.
January 2021 MIVI Neuroscience Inc $35,000,000 series B financing sole placement agent

January 2021

About MIVI Neuroscience Inc.

MIVI Neuroscience, Inc. is focused on developing and commercializing superior clinical solutions for neurointerventional procedures.
January 2021 Neogenomics $230,000,000 common stock offering $345,000,000 convertible senior notes co-manager

January 2021

About Neogenomics

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer.
January 2021 Innovative Renal Care has received equity funding from Nautic

January 2021

About Innovative Renal Care

Innovative Renal Care is a network of dialysis professionals devoted to helping people with kidney disease lead their best lives as they undergo treatment.
January 2021 NGM Biopharmaceuticals Inc $143,750,000 follow-on offering lead manager

January 2021

About NGM Biopharmaceuticals Inc.

NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer.
January 2021 REGENXBIO $230,253,000 follow-on offering lead manager

January 2021

About REGENXBIO

REGENXBIO Inc. is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10.
January 2021 Icotec Financial advisor

January 2021

About Icotec

Icotec develops and manufactures innovative, high-strength implants from carbon-fiber-reinforced plastic for the treatment of patients in the areas of spinal and trauma surgery.
December 2020 Ocular Therapeutix $92,101,000 follow-on offering co-manager

December 2020

About Ocular Therapeutix

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology.
December 2020 Beaumont Health has sold multiple companies to Superior Ambulance Service

December 2020

About Beaumont Health

Beaumont Health is Michigan’s largest health care system (based on inpatient admissions and net patient revenue) and provides patients with compassionate, extraordinary care, no matter where they live.
December 2020 MedTech Acquisition Corporation $250M initial public offering sole bookrunning manager

December 2020

About MedTech Acquisition Corporation

The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
December 2020 Addus Homecare has acquired Queencity $192M

December 2020

About Addus Homecare

Addus is a provider of comprehensive home care services that include, primarily, personal care services that assist with activities of daily living, as well as hospice and home health services.
November 2020 Binary Fountain has been acquired by Press Ganey

November 2020

About Binary Fountain

Binary Fountain provides the leading customer experience and online reputation management platform for enterprises, healthcare organizations and small and medium-sized businesses.
November 2020 Mission Healthcare has been acquired by Vistria

November 2020

About Mission Healthcare

Mission Healthcare is a leading hospice and skilled home health provider in Southern California serving over 2,200 patients daily.
November 2020 Allied Dental a portfolio company of Riverside has merged with PG Dental

November 2020

About Allied Dental

Allied Dental is a dental services organization providing non-clinical administrative services to dental practices in the Northeast and Mid-Atlantic.
November 2020 PLx Pharma Inc PIPE sole placement agent

November 2020

About PLx Pharma Inc

PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products.
October 2020 Phreesia $184,000,000 follow-on offering co-manager

October 2020

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process.
October 2020 ThermoTek Inc has been acquired by Havencrest

October 2020

About ThermoTek Inc

Founded in 1993 and based in Flower Mound, TX, ThermoTek, Inc. provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications.
October 2020 Ocular Therapeutix $80,506,000 follow-on offering co-manager

October 2020

About Ocular Therapeutix

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology.
October 2020 Tarsus Pharmaceuticals Inc $101,200,000 initial public offering bookrunning manager

October 2020

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions where there are limited treatment alternatives.
September 2020 GoodRx $1,313,653,803 initial public offering co-manager

September 2020

About GoodRx

GoodRx’s leading digital platform for consumer healthcare products and services connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests.
September 2020 Adamis Pharmaceuticals follow-on offering bookrunning manager

September 2020

About Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy.
September 2020 Proteus Digital Health has been acquired by Otsuka

September 2020

About Proteus Digital Health

Armed with more than 500 issued patents and led by some of the brightest minds in technology, pharmaceuticals and health care, Proteus Digital Health invented Digital Medicine, helps physicians improve clinical outcomes and patients reach health goals.
August 2020 Vision Group Holdings has been acquired by LasikPlus

August 2020

About Vision Group Holdings

Vision Group Holdings, based in West Palm Beach, Florida oversees and manages two of the leading LASIK surgery providers in the world: The LASIK Vision Institute and TLC Laser Eye Centers.
August 2020 Simulations Plus $115,000,000 follow-on offering bookrunning manager

August 2020

About Simulations Plus

Simulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services.
July 2020 BioTheryx $35M private placement sole placement agent

July 2020

About BioTheryx

BioTheryX is a clinical stage biotechnology company focused on creating new classes of drugs for unmet medical needs based on targeted protein degradation and multi-kinase inhibition. Its lead drug candidate, BTX-A51, is an orally available small molecule, multi-kinase inhibitor for cancers and inflammatory diseases.
July 2020 HealthEquity $258,000,000 follow-on offering co-manager

July 2020

About HealthEquity

HealthEquity administers Health Savings Accounts (HSAs) and other consumer-directed benefits for our more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers.
June 2020 PolyPid $69M initial public offering lead manager

June 2020

About PolyPid

PolyPid is a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary Polymer-Lipid Encapsulation matriX, or PLEX, technology.
June 2020 Progenity $100,000,000 initial public offering bookrunning manager

June 2020

About Progenity

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine.
June 2020 Compass Therapeutics $60,482,000 Alternative public offering lead placement agent

June 2020

About Compass Therapeutics

Compass Therapeutics is a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and multispecific antibody therapeutics.
June 2020 Artiva Biotherapeutics $78,000,000 series a mezzanine financing financial advisor

June 2020

About Artiva Biotherapeutics

Artiva’s focus is to deliver cancer patients highly effective cellular immunotherapies that are also safe and immediately accessible.
June 2020 Catalyst Biosciences $30M follow-on offering sole bookrunning manager

June 2020

About Catalyst Biosciences

Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and systemic complement-mediated disorders.
June 2020 Leap Therapeutics $51,750,000 follow-on offering bookrunning manager

June 2020

About Leap Therapeutics

Leap Therapeutics (Nasdaq:LPTX) is focused on developing targeted and immuno-oncology therapeutics.
June 2020 QGenda a portfolio company of  FP has received an investment from Iconiq

June 2020

About QGenda

QGenda is a leading innovator of provider scheduling, clinical capacity management and labor analytics.
June 2020 OraSure Technologies $101,200,000 follow-on offering co-manager

June 2020

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate essential information.
May 2020 Flexion Therapeutics $103,500,000 follow-on offering co-manager

May 2020

About Flexion Therapeutics

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis.
May 2020 Ayala Pharmaceuticals $59,110,000 initial public offering co-manager

May 2020

About Ayala Pharmaceuticals

Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations.
May 2020 Ocular Therapeutix $51,750,000 follow-on offering co-manager

May 2020

About Ocular Therapeutix

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology.
May 2020 BioPlus Specialty Pharmacy has been acquired by Nautic

May 2020

About BioPlus Specialty Pharmacy

Headquartered in Altamonte Springs, Florida, BioPlus Specialty Pharmacy (“BioPlus” or the “Company”) is a leading independent specialty pharmacy with service capabilities in all 50 states, servicing over 10,000 patients and filling over 100,000 prescriptions annually
May 2020 Neogenomics $125,400,000 common stock offering $175,000,000 convertible senior notes co-manager

May 2020

About Neogenomics

NeoGenomics, Inc. specializes in cancer genetics testing and information services.
April 2020 VBI Vaccines $57,500,000 follow-on offering bookrunning manager

April 2020

About VBI Vaccines

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
April 2020 Health Catalyst $230,000,000 2.50% convertible senior notes due 2025

April 2020

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement.
April 2020 Wellbeing Software a portfolio company of Elysian Capital has been acquired by Citadel Group

April 2020

About Wellbeing Software

Wellbeing Software is a healthcare technology provider with a presence in more than 80% of NHS organisations.
March 2020 Enovate Medical a portfolio company of Riverside Partners Minority Recapitalization

March 2020

About Enovate Medical

Information coming soon
March 2020 Epigenomics private placement sole placement agent

March 2020

About Epigenomics

Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology.
March 2020 TNI Medical has been acquired by Masimo

March 2020

About TNI Medical

Headquartered in Wuerzburg, Germany, TNI Medical AG (“TNI”) is an innovative medical technology company active in the ventilation space.
March 2020 eHealth $238,050,000 follow-on offering co-manager

March 2020

About eHealth

eHealth, Inc. (Nasdaq: EHTH) is a leading health insurance marketplace that was incorporated in Delaware in November 1997.
February  2020 Catalyst Biosciences $34,500,000 follow-on offering sole bookrunning manager

February 2020

About Catalyst Biosciences

Catalyst Biosciences is a clinical-stage biopharmaceutical company which is focused on addressing unmet needs in rare diseases and systemic complement mediated disorders.
February 2020 Sol-Gel Technologies Ltd follow-on offering lead manager

February 2020

About Sol-Gel Technologies Ltd

Sol-Gel Technologies, Ltd. is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
January 2020 Mirum Pharmaceuticals $48,000,000 follow-on offering lead manager

January 2020

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
January 2020 AvKARE majority interest has been acquire by Amneal $340,000,000

January 2020

About AvKARE

AvKARE is one of the largest private label distributors of generic pharmaceuticals into the U.S. federal agency sector, primarily serving the Department of Defense and Department of Veterans Affairs.
January 2020 Leap Therapeutics $27,000,000 PIPE sole placement agent

January 2020

About Leap Therapeutics

Leap Therapeutics (Nasdaq:LPTX) is focused on developing targeted and immuno-oncology therapeutics.
January 2020 Zymeworks $320,850,000 follow-on offering lead manager

January 2020

About Zymeworks

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
January 2020 Profound Medical Corp $39,522,625 follow-on offering co-manager

January 2020

About Profound Medical Corp.

Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.
December 2019 Phreesia $201,825,000 follow-on offering co-manager

December 2019

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process.
December 2019 Bradford Health Services a portfolio company of Centrepartners senior and subordinated debt facilities

December 2019

About Bradford Health Services

Information coming soon
October 2019 Quantros a portfolio company of FP has divested its patient safety business to RLDatix

October 2019

About Quantros

Quantros is a leading provider of software-based solutions and services to healthcare.
October 2019 Addus Homecare has acquired Hospice Partners of America a portfolio company of New Capital Partners $130M

October 2019

About Addus Homecare

Addus is a provider of comprehensive home care services that include, primarily, personal care services that assist with activities of daily living, as well as hospice and home health services.
September 2019 VBI Vaccines $40,250,000 follow-on offering bookrunning manager

September 2019

About VBI Vaccines

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
September 2019 Addus Homecare $182,850,000 follow-on offering bookrunning manager

September 2019

About Addus Homecare

Addus is a provider of comprehensive home care services that include, primarily, personal care services that assist with activities of daily living, as well as hospice and home health services.
August 2019 Benefit Resource Inc has been acquired by CIP Capital

August 2019

About Benefit Resource Inc.

Benefit Resource Inc. administers pre-tax benefit plans and COBRA services nationwide. Unlike payroll or human resource companies, BRI focuses and brings expertise to the administration of benefit accounts, COBRA and direct billing administration services.
August 2019 Adamis Pharmaceuticals follow-on offering bookrunning manager

August 2019

About Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy and opioid overdose.
July 2019 Ziopharm Oncology $45M private placement sole placement agent

July 2019

About Ziopharm Oncology

Ziopharm Oncology is an immuno-oncology company focused on developing end-to-end cost-effective solutions using its non-viral Sleeping Beauty platform for TCR and CAR T-cell therapies and immune-stimulating gene therapy with Controlled interleukin 12 (IL-12).
July 2019 Advent International has acquired Definitive Healthcare a portfolio company of Spectrum Equity

July 2019

About Advent International

Information coming soon.
July 2019 Cancer Genetics Biopharma and Clinical Businesses have been acquired by multiple companies

July 2019

About Cancer Genetics

Cancer Genetics develops, commercializes, and provides molecular and biomarker-based tests and services which diagnose, monitor and inform cancer treatment.
July 2019 Mirum Pharmaceuticals $75M initial public offering lead manager

July 2019

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
July 2019 Bridge Bio Pharma $400,775,000 initial public offering bookrunning manager

July 2019

About Bridge Bio Pharma

BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source.
June 2019 Rhapsody a portfolio company of Hg has merged with Corepoint Health

June 2019

About Rhapsody

Rhapsody is an industry-leading interoperability platform that enhances healthcare ecosystems through seamless connectivity to unlock the potential of data, on-premises and in the cloud.
June 2019 Nystrom and  Associates has been recapitalized by Nautic

June 2019

About 1906_Nystrom and Associates

Nystrom & Associates is a leading regional provider of outpatient and home- and community-based mental health, behavioral health, and substance use disorder treatment services.
June 2019 ADMA Biologics secondary share sale sole agent on behalf of Biotest Trust

June 2019

About ADMA Biologics

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
June 2019 Premier has sold Commcare Specialty Pharmacy | ACRO to CVS Health

June 2019

About Premier

Information coming soon.
June 2019 Zymeworks $201,250,476 follow-on offering co-lead manager

June 2019

About Zymeworks

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.
May 2019 Avantor Inc $3,332,700,000 initial public offering $1,035,000,000 convertible preferred stock co-manager

May 2019

About Avantor Inc.

Avantor is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
May 2019 NeoGenomics $148,800,000 follow-on offering co-manager

May 2019

About NeoGenomics

NeoGenomics, Inc. specializes in cancer genetics testing and information services.
May 2019 ADMA Biologics Inc. $51,750,000 follow-on offering bookrunning manager

May 2019

About ADMA Biologics Inc.

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
May 2019 Vidyo has been acquired by Enghouse Systems

May 2019

About Vidyo

Vidyo enriches people's lives by embedding real-time video into digital communications in the moments that matter most.
May 2019 North Florida Ob-Gyn has been acquired by Women's Care Enterprises a portfolio company of  Lindsay Goldberg

May 2019

About North Florida Ob-Gyn

North Florida Ob-Gyn is the largest independent women's health practice in Jacksonville, providing patients with individualized, state-of-the-art, and high-quality care in obstetrics, gynecology and urogynecology across 38 locations.
April 2019 Prometic C$75,000,000 PIPE joint placement agent

April 2019

About Prometic

Prometic is a biopharmaceutical corporation with two drug discovery platforms focusing on unmet medical needs.
April 2019 Brainsway $27,500,000 initial public offering bookrunning manager

April 2019

About Brainsway

Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products.
April 2019 Sundance Behavioral Healthcare has been acquired by Perimeter Healthcare a portfolio company of Ridgemont

April 2019

About Sundance Behavioral Healthcare

Founded in 2005, Sundance is a provider of acute and outpatient behavioral and substance use disorder services.
March 2019 Asterias Biotherapeutics has been acquired by Biotime

March 2019

About Asterias Biotherapeutics

Asterias Biotherapeutics, Inc. is a biotechnology company pioneering the field of regenerative medicine.
March 2019 IMV C$26,705,000 follow-on offering bookrunning manager

March 2019

About IMV

Information coming soon.
February 2019 Leap Therapeutics follow-on offering lead bookrunning manager

February 2019

About Leap Therapeutics

Leap Therapeutics is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator.
February 2019 Cambio Healthcare Systems a portfolio company of Valedo has been acquired by Investcorp

February 2019

About Cambio Healthcare Systems

Cambio operates in the Electronic Health Records (“EHR") market, offering software solutions for acute, primary, social and person-centred care.
January 2019 Applied Plastics has been acquired by Vance Street Capital

January 2019

About Applied Plastics

Founded in 1953 and headquartered in Norwood, Massachusetts, Applied Plastics is a leading advanced coatings company, providing specialty PTFE coatings on wires and other metal-based components for the medical device industry.
January 2019 Jvion has received a significant growth investment from JMI Equity

January 2019

About Jvion

Jvion delivers healthcare’s only Cognitive Clinical Success Machine. Using Eigen-based technology, the machine does what simple predictive analytics or machine learning models cannot.
January 2019 Orasure Technologies has acquired CoreBiome

January 2019

About Orasure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of point-of-care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions.
December 2018 Nassau Anesthesia Associates has been acquired by Envision Healthcare a portfolio company of KKR

December 2018

About Nassau Anesthesia Associates

Information coming soon.
December 2018 Ra Pharma $149,500,000 follow-on offering co-manager

December 2018

About Ra Pharma

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases.
December 2018 Viveve $22,100,000 follow-on offering lead manager

December 2018

About Viveve

Viveve Medical, Inc. is a women’s intimate health company committed to advancing new solutions to improve women’s overall well-being and quality of life.
November 2018 Viacyte led by Bain Capital | TPG |  RACapital $81,000,000 private placement exclusive financial advisor

November 2018

About Viacyte

ViaCyte is a privately held regenerative medicine company developing novel cell replacement therapies as potential long-term diabetes treatments to achieve glucose control targets and reduce the risk of hypoglycemia and diabetes-related complications
November 2018 AscoPharm a portfolio company of Pagoda Adiuva Capital acquired by Point Rouge

November 2018

About Pagoda

PAGODA is a private equity investment platform backed primarily by European institutions and specializes in growth capital for Chinese technology super stars.
November 2018 Ziopharm $50,000,000 PIPE sole placement agent

November 2018

About Ziopharm

Ziopharm Oncology is a biotechnology company focused on next-generation immunotherapies utilizing gene- and cell-based therapies to treat patients with cancer.
October 2018 Epigenomics private placement of unsubscribed shares following a rights offering sole placement offering

October 2018

About Epigenomics

Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology.
October 2018 Hg has acquired certain assets of Orion Health NZD 205,000,000

October 2018

About Hg

HG Capital is a venture capital and private equity firm specializing in start-ups, early venture, growth capital, and mature investments.
October 2018 Provant Health has been acquired by an affiliate of Quest diagnostics

October 2018

About Provant Health

Founded in 1899, Hooper Holmes, d/b/a Provant Health is a provider of comprehensive health and wellbeing programs offered through organizations’ sponsorship.
October 2018 Great Call a portfolio company of GTCR has been acquired by Best Buy

October 2018

About Great Call

GreatCall is a leading provider of connected health and personal emergency response services to the aging population, with more than 900,000 paying subscribers.
October 2018 Merit Medical has entered into a definitive agreement to acquire Cianna Medical

October 2018

About Merit Medical

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy.
September 2018 Viking Therapeutics $175,750,000 follow-on offering bookrunning manager

September 2018

About Viking Therapeutics

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
September 2018 Nuvectra $69,036,000 follow-on offering co-manager

September 2018

About Nuvectra

Nuvectra is a neuromodulation medical device company focused on the development of its neurostimulation technology platform for the treatment of various disorders through the stimulation of tissues associated with the nervous system.
August 2018 Addus Homecare $124,000,000 follow-on offering bookrunning manager

August 2018

About Addus Homecare

Addus is a provider of home care services that include, primarily, personal care services that assist with activities of daily living, as well as hospice and home health services.
August 2018 Avella has been acquired by Optum

August 2018

About Avella

Information coming soon.
August 2018 Up-Med has been acquired by Philips

August 2018

About Up-Med

Information coming soon.
August 2018 REGENXBIO $201,825,000 follow-on offering co-manager

August 2018

About REGENXBIO

REGENXBIO Inc. is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.
August 2018 Acer Therapeutics $46,000,000 follow-on offering bookrunning manager

August 2018

About Acer Therapeutics

Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need.
August 2018 Adamis Pharmaceuticals Corporation $40,250,000 follow-on offering bookrunning manager

August 2018

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy.
July 2018 Merit Medical Systems Inc $189,000,000 follow-on offering co-manager

July 2018

About Merit Medical Systems Inc.

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy.
July 2018 Careforce has been acquired by findosinvestor

July 2018

About Careforce

Careforce is a home health care agency, serving clients and their families.
July 2018 MDLIVE has received a strategic investment from Healty Velocity Capital | Cigna | HCSC $50M

July 2018

About MDLIVE

Founded in 2009, MDLIVE Inc. is a pioneer in the digital delivery of high-quality, convenient, cost-efficient virtual care for medical, dermatological and behavioral health conditions.
June 2018 Capvis has acquired a majority stake in Amanngirrbach a portfolio company of TA Associates

June 2018

About Capvis

Capvis is a private equity firm focused on leveraged buyout and growth capital investments in middle-market companies across a range of industries in Switzerland, Austria and Germany.
June 2018 Galmed Pharmaceuticals $75,000,000 follow-on offering lead manager

June 2018

About Galmed Pharmaceuticals

Galmed is a clinical-stage biopharmaceutical company focused on the development of Aramchol, a first in class, novel, once-daily, oral therapy for the treatment of NASH for variable populations.
June 2018 Belmont Instrument Corporation portfolio company of Audax Group acquired MTRE

June 2018

About Belmont Instrument Corporation

Belmont Instrument Corporation develops fluid management and medical devices for global use in medical facilities and military combat fields. It offers blood and fluid warmers.
June 2018 Connect America senior secured notes financing provided by Goldman Sachs Fortress Crestline Comvest

June 2018

About Connect America

Connect America is the largest independent company in the North American Personal Emergency Response Systems (“PERS”) industry, the leading provider in the direct-to-consumer segment and the fastest growing provider in the healthcare segment.
June 2018 ADMA Biologics $46,000,000 follow-on offering bookrunning manager

June 2018

About ADMA Biologics

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
June 2018 Deciphera $197,800,000 follow-on offering co-manager

June 2018

About Deciphera

Deciphera is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies.
June 2018 Zymeworks $97,807,500 follow-on offering bookrunning manager

June 2018

About Zymeworks

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.
June 2018 Maxwell Health has been acquired by Sun Life Financial

June 2018

About Maxwell Health

Maxwell Health simplifies benefits and HR for small-to-mid-sized employers, helping their employees achieve better health and financial security.
May 2018 R1 RCM has acquired Intermedix

May 2018

About R1 RCM

R1 is a leading provider of technology-enabled revenue cycle management services which transform a health system’s revenue cycle performance across settings of care.
April 2018 RedBrick Health has been acquired by Marlin Equity Partners

April 2018

About RedBrick Health

RedBrick Health is a health technology and services company based in Minneapolis, Minnesota. RedBrick Health is privately held and works with large, self-insured employers, progressive health plans, providers and accountable care organizations.
April 2018 Bellicum Pharmaceuticals Inc. $69,000,000 follow-on offering co-manager

April 2018

About Bellicum Pharmaceuticals Inc.

Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.
April 2018 Connecture has been acquired by FP

April 2018

About Connecture

Connecture is a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Connecture offers a personalized health insurance shopping experience that recommends the best fit insurance plan.
March 2018 Icon Bioscience has been acquired by pSivida to form EyePoint Pharmaceuticals

March 2018

About Icon Bioscience

Icon Bioscience Inc. (IBI) a privately held specialty biopharma company, is pioneering a transformational change in the delivery of ophthalmic pharmaceuticals by focusing on the development and commercialization of novel intraocular therapeutics based on our proprietary and patented drug delivery platform, Verisome®.
March 2018 RAF | Orion have been acquired by Radiology Partners a portfolio company of NEA

March 2018

About Radiology Associates of Florida, P.A.

Over the last 40 plus years, Radiology Associates of Florida has expanded its practice to 53 Board certified radiologists’ who sub-specialize in all sub specialties of radiology.
March 2018 Leap Therapeutics follow-on offering lead bookrunning manager

March 2018

About Leap Therapeutics

Leap Therapeutics is developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator.
March 2018 Alphatec Spine has acquired SafeOp Surgical

March 2018

About Alphatec Spine

Alphatec Holdings, Inc., through its wholly-owned subsidiary of Alphatec Spine, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma.
February 2018 Adverum Biotechnologies $69,000,000 follow-on offering lead manager

February 2018

About Adverum Biotechnologies

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.
February 2018 Viveve Medical $34,500,000 follow-on offering lead manager

February 2018

About Viveve Medical

Viveve designs, develops, manufactures and markets a medical device for the non-invasive treatment of vaginal introital laxity, for improved sexual function, for vaginal rejuvenation, and for use in general surgery for electrocoagulation and hemostasis.
February 2018 Gemphire Therapeutics Inc. $25,150,000 follow-on offering bookrunning manager

February 2018

About Gemphire Therapeutics Inc.

Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH.
February 2018 Office Practicum a portfolio company of Bluffpoint Associates has been acquired by Pamlico Capital

February 2018

About Office Practicum

Office Practicum is a top ranked provider of electronic health record and practice management software for use in ambulatory primary care settings.
January 2018 Sol-Gel Technologies Ltd. $86,250,000 initial public offering co-manager

January 2018

About Sol-Gel Technologies Ltd.

Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
November 2017 Leap Therapeutics PIPE lead placement agent

November 2017

About Leap Therapeutics

Leap Therapeutics is developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator.
November 2017 ConnectiveRX has acquired Careform

November 2017

About ConnectiveRX

ConnectiveRx was formed in late 2015 by bringing together PSKW, pioneers in affordability solutions, and PDR, innovators in advanced adherence communications products.
November 2017 ADMA Biologics $41,975,000 follow-on offering bookrunning manager

November 2017

About ADMA Biologics

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
November 2017 American Addiction Centers unregistered block trade sole manager

November 2017

About American Addiction Centers

American Addiction Centers is a leading provider of inpatient substance abuse treatment services. The company treats adults as well as adolescents who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues.
October 2017 Corbus Pharmaceuticals Holdings Inc $37,433,000 follow-on offering co-manager

October 2017

About Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.
October 2017 BioTime Inc. $28,750,000 follow-on offering bookrunning manager

October 2017

About BioTime Inc.

BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Company’s current clinical programs are targeting three primary sectors, aesthetics, ophthalmology and cell/drug delivery.
October 2017 Flexion Therapeutics, Inc. $140,760,000 follow-on offering co-lead manager

October 2017

About Flexion Therapeutics Inc.

Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (“OA”).
October 2017 Ardian has acquired a majority stake of Imes-Icore

October 2017

About Ardian

Ardian, founded in 1996 and led by Dominique Senequier, is an independent private investment company with assets of USD 62 billion managed or advised in Europe, North America and Asia.
September 2017 Juno Therapeutics Inc. $287,615,000 follow-on offering co-manager

September 2017

About Juno Therapeutics Inc.

Juno Therapeutics is building a fully integrated biopharmaceutical company focused on developing innovative cellular immunotherapies for the treatment of cancer.
September 2017 Jacksonville Anesthesia Corporation has been acquired by US Anesthesia Partners a portfolio company of WCAS

September 2017

About Jacksonville Anesthesia Corporation

Florida Anesthesia Associates and Jacksonville Anesthesia Corporation comprise over 50 clinicians who provide inpatient and outpatient anesthesia services in Northeast Florida to Baptist Health System and other clinical sites across a wide-range of surgical subspecialties including neuroendovascular, cardiac, vascular, electrophysiologic & structural cardiology, orthopedic, otolaryngology, and ophthalmology.
September 2017 Florida Anesthesia Associates has been acquired by US Anesthesia Partners A portfolio company of WCAS

September 2017

About Florida Anesthesia Associates

Florida Anesthesia Associates P.A is a group of highly qualified Physician Anesthesiologists formed in 1994 to provide organized single group anesthesia coverage to Baptist Medical Center Jacksonville in Jacksonville, FL.
August 2017 BHT Group has been acquired by Cantel-Medical

August 2017

About BHT Group

BHT Group, including BHT Hygienetechnik and ESCAD Medical, is the leading German company for reprocessing of endoscopes and medical instruments.
August 2017 Healthcare Bluebook has been acquired by Primus

August 2017

About Healthcare Bluebook

Healthcare Bluebook works with employers to make healthcare price and quality transparency available to their employees and directly via our website and mobile apps to provide Fair Price™ information to everyone.
July 2017 Dubag has entered into a definitive agreement to sell Lomapharm to multiple companies

July 2017

About Dubag

DUBAG is an independent private equity firm that is specialized on investments in well-positioned mid-sized companies with potential for growth.
July 2017 BioTelemetry has acquired Life Watch

July 2017

About BioTelemetry

BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.
June 2017 Centogene has closed a series A financing with multiple companies

June 2017

About Centogene

CENTOGENE AG provides test portfolios of over 3,100 single genes and over 200 panels. The company is currently receiving samples from over 110 countries, with approximately 120,000 analyzed individuals in its database, CentoMD®.
June 2017 Akebia Therapeutics Inc $66,700,000 follow-on offering

June 2017

About Akebia Therapeutics Inc.

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology.
June 2017 Qvella private placement exclusive financial advisor

June 2017

About Qvella

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the goal of dramatically reducing time to results in bacteriology.
June 2017 Plx Pharma Inc. registered direct lead placement agent

June 2017

About Plx Pharma Inc.

PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on developing its clinically validated and patent-protected PLxGuard™ delivery system to provide safe and effective aspirin products.
June 2017 GenMark Diagnostics $86,250,000 follow-on offering co-manager

June 2017

About GenMark Diagnostics

GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing high-value, simple to perform, clinically relevant multiplex molecular tests based on the Company’s proprietary eSensor electrochemical detection technology.
June 2017 ADMA Biologics has acquired certain assets from Biotest

June 2017

About ADMA Biologics

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
May 2017 RPS Diagnostics have been acquired by Quidel Corporation

May 2017

About RPS Diagnostics

Founded in 2004, RPS Diagnostics (RPS) is an emerging developer, manufacturer, and marketer of rapid point-of-care diagnostic tests.
May 2017 Provant has merged with HooperHolmes

May 2017

About Provant

Provant is a national health and well-being leader that works with organizations across all industries to improve members' whole-person health.
May 2017 Cranial Technologies Inc. a portfolio company of  Cortec Group has been acquired by Beecken Petty O'Keefe & Company

May 2017

About Cranial Technologies Inc.

Founded in 1988, CranialTech is a leading developer, manufacturer and provider of medical devices and services for the treatment of positional plagiocephaly in infants. The Company’s mission is to provide a superior product, service, and the best possible outcome for every child with an abnormal head shape.
May 2017 UroGen Pharma Ltd. $66,877,000 initial public offering co-manager

May 2017

About UroGen Pharma Ltd.

UroGen Pharma Ltd. operates as a clinical stage biopharmaceutical company. The Company focuses on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology.
May 2017 Renal Ventures Management LLC has been acquired by DaVita

May 2017

About Renal Ventures Management LLC

Renal Ventures Management, LLC provides dialysis care and information for people living with chronic kidney disease in the United States.
April 2017 Adamis Pharmaceuticals Corporation follow-on offering bookrunning manager

April 2017

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy.
April 2017 Care Hospice has been recapitalized by Capricorn Healthcare

April 2017

About Care Hospice

Formed in 2014 via the merger of two regional hospice providers, today the Care Hospice platform operates in eight states and serves over 830 patients daily.
March 2017 ALung Technologies Inc. $36,000,000 private placement lead placement agent

March 2017

About ALung Technologies Inc.

ALung Technologies, Inc. is a privately-held Pittsburgh-based developer and manufacturer of innovative lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung RAS as a dialysis-like alternative or supplement to mechanical ventilation.
March 2017 Blueprint Medicines Corporation $230,000,000 follow-on offering co-manager

March 2017

About Blueprint Medicines Corporation

Blueprint Medicines is developing a new generation of targeted and potent kinase medicines to improve the lives of patients with genomically defined diseases.
March 2017 Bellicum Pharmaceuticals Inc. $69,000,000 follow-on offering co-manager

March 2017

About Bellicum Pharmaceuticals Inc.

Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.
March 2017 Merit Medical Systems Inc. $146,200,000 follow-on offering co-manager

March 2017

About Merit Medical Systems Inc.

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy.
March 2017 Vital Therapies Inc. $40,250,000 follow-on offering bookrunning manager

March 2017

About Vital Therapies Inc.

Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute forms of liver failure. The Company’s ELAD System is an extracorporeal human allogeneic cellular liver therapy currently in phase 3 clinical trials.
March 2017 Aerpio Pharmaceuticals Inc. $40,000,000 private placement lead placement agent

March 2017

About Aerpio Pharmaceuticals Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB-9778, is a small molecule activator of the Tie2 pathway and is in clinical development for diabetic retinopathy.
March 2017 Viveve $34,500,000 follow-on offering bookrunning manager

March 2017

About Viveve

Viveve designs, develops, manufactures and markets a medical device for the non-invasive treatment of vaginal introital laxity, for improved sexual function, for vaginal rejuvenation, and for use in general surgery for electrocoagulation and hemostasis
March 2017 Connecture has received an investment from FP $17,500,000

March 2017

About Connecture

Connecture is a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Connecture offers a personalized health insurance shopping experience that recommends the best fit insurance plan.
March 2017 Medical Optics has been acquired by Alpha Source Inc.

March 2017

About Medical Optics

Medical Optics is the industry leader for equipment, endoscope and instrument repair including complete restoration needs. Since its launch in 1997, every piece of equipment has been repaired with expert precision and unparalleled care at a state-of-the art facility.
February 2017  MobileHelp has been acquired by Abry Partners

February 2017

About MobileHealth

Headquartered in the Research Park at Florida Atlantic University, MobileHelp is a leading provider of mobile Personal Emergency Response Systems (PERS) and health management solutions.
February  2017 BioTime Inc. follow-on offering bookrunning manager

February 2017

About BioTime Inc.

BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine. The foundation of its core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body.
January 2017 Cascadian Therapeutics Inc. $94,000,000 follow-on offering lead manager

January 2017

About Cascadian Therapeutics Inc.

Cascadian Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative product candidates for the treatment of cancer.
January 2017 Macrocure Ltd has merged with LeapTherapeutics $100,000,000

January 2017

About Macrocure Ltd

Macrocure Ltd. is a clinical-stage biotechnology company that was focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds.

Transaction history may include transactions completed by a Raymond James banker while at a former firm.